Worth a Look
Qualify for a free subscription to HealthLeaders magazine.
“Bandages” and “shrimp” are two words you don’t expect to hear in the same sentence. But for one Portland, OR-based company, they go together just fine.
HemCon Medical Technologies worked with the U.S. Army to develop a bandage made from chitosan, a naturally occurring, biocompatible substance derived from shrimp shells. The shells are processed, treated, formed into bandages and sterilized. The idea is that the chitosan attracts blood cells and seals a wound to allow the body to form a clot that stops hemorrhaging. And what if the patient has a shellfish allergy? HemCon says no known allergic reactions have occurred since the product launched in 2003.
Originally developed for use on the battlefield, the dressings are now used in acute-care settings through a distributorship agreement reached last fall with Dublin, OH-based Cardinal Health. Go to either www.hemcon.com or www.cardinalhealth.com to read more.
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- House Lawmakers Grill CMS Over Health Exchange Navigators
- Fortunately, Angelina Jolie Isn't On Medicare
- Don't Let Nurses Sink Your Bottom Line
- How Chargemaster Data May Affect Hospital Revenue
- Uncompensated Care Faces a Double Hit in Some States
- Hospital Pricing Transparency a Marketing Game Changer
- ED Physicians Key to Half of Hospital Admissions
- Primary Care Docs Average More Hospital Revenue Than Specialists
- Insurer's App Aims to Lower Healthcare Costs, Securely